1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

VHCP Management II, LLC Buys Tricida Inc, DBV Technologies SA, Kiniksa Pharmaceuticals, Sells AveXis Inc, AnaptysBio Inc, DBV Technologies SA

Investment company VHCP Management II, LLC buys Tricida Inc, DBV Technologies SA, Kiniksa Pharmaceuticals, Kadmon Holdings Inc, Marinus Pharmaceuticals Inc, Apellis Pharmaceuticals Inc, ChemoCentryx Inc, sells AveXis Inc, AnaptysBio Inc, DBV Technologies SA, Menlo Therapeutics Inc, Savara Inc during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, VHCP Management II, LLC. As of 2018-06-30, VHCP Management II, LLC owns 18 stocks with a total value of $334 million. These are the details of the buys and sells.

For the details of VHCP Management II, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=VHCP+Management+II%2C+LLC

These are the top 5 holdings of VHCP Management II, LLC
  1. Endocyte Inc (ECYT) - 4,300,000 shares, 17.76% of the total portfolio.
  2. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 1,415,391 shares, 16.74% of the total portfolio. Shares added by 1.80%
  3. ObsEva SA (OBSV) - 2,252,460 shares, 10.21% of the total portfolio. Shares added by 5.07%
  4. Ascendis Pharma A/S (ASND) - 504,210 shares, 10.04% of the total portfolio. Shares reduced by 13.99%
  5. argenx SE (ARGX) - 346,792 shares, 8.68% of the total portfolio.
New Purchase: Tricida Inc (TCDA)

VHCP Management II, LLC initiated holding in Tricida Inc. The purchase prices were between $26 and $29.9, with an estimated average price of $27.95. The stock is now traded at around $23.50. The impact to a portfolio due to this purchase was 8.62%. The holding were 962,696 shares as of 2018-06-30.

New Purchase: DBV Technologies SA (DBVT)

VHCP Management II, LLC initiated holding in DBV Technologies SA. The purchase prices were between $18.6 and $24.94, with an estimated average price of $22.54. The stock is now traded at around $19.00. The impact to a portfolio due to this purchase was 3.6%. The holding were 463,149 shares as of 2018-06-30.

New Purchase: Kiniksa Pharmaceuticals Ltd (KNSA)

VHCP Management II, LLC initiated holding in Kiniksa Pharmaceuticals Ltd. The purchase prices were between $16.73 and $20.35, with an estimated average price of $18.13. The stock is now traded at around $14.68. The impact to a portfolio due to this purchase was 3.32%. The holding were 639,230 shares as of 2018-06-30.

New Purchase: Kadmon Holdings Inc (KDMN)

VHCP Management II, LLC initiated holding in Kadmon Holdings Inc. The purchase prices were between $3.35 and $4.39, with an estimated average price of $3.91. The stock is now traded at around $3.47. The impact to a portfolio due to this purchase was 1.69%. The holding were 1,411,428 shares as of 2018-06-30.

New Purchase: Marinus Pharmaceuticals Inc (MRNS)

VHCP Management II, LLC initiated holding in Marinus Pharmaceuticals Inc. The purchase prices were between $3.8 and $7.7, with an estimated average price of $5.53. The stock is now traded at around $5.98. The impact to a portfolio due to this purchase was 0.73%. The holding were 345,240 shares as of 2018-06-30.

New Purchase: Apellis Pharmaceuticals Inc (APLS)

VHCP Management II, LLC initiated holding in Apellis Pharmaceuticals Inc. The purchase prices were between $19.63 and $30, with an estimated average price of $23.02. The stock is now traded at around $18.46. The impact to a portfolio due to this purchase was 0.2%. The holding were 29,710 shares as of 2018-06-30.

Sold Out: AveXis Inc (AVXS)

VHCP Management II, LLC sold out a holding in AveXis Inc. The sale prices were between $115.91 and $217.83, with an estimated average price of $198.8.

Sold Out: AnaptysBio Inc (ANAB)

VHCP Management II, LLC sold out a holding in AnaptysBio Inc. The sale prices were between $70.01 and $96.33, with an estimated average price of $83.98.

Sold Out: DBV Technologies SA (DBVTF)

VHCP Management II, LLC sold out a holding in DBV Technologies SA. The sale prices were between $44.24 and $48.46, with an estimated average price of $45.69.

Sold Out: Menlo Therapeutics Inc (MNLO)

VHCP Management II, LLC sold out a holding in Menlo Therapeutics Inc. The sale prices were between $7.79 and $36.99, with an estimated average price of $10.83.

Sold Out: Savara Inc (SVRA)

VHCP Management II, LLC sold out a holding in Savara Inc. The sale prices were between $8.55 and $13.76, with an estimated average price of $10.03.



Here is the complete portfolio of VHCP Management II, LLC. Also check out:

1. VHCP Management II, LLC's Undervalued Stocks
2. VHCP Management II, LLC's Top Growth Companies, and
3. VHCP Management II, LLC's High Yield stocks
4. Stocks that VHCP Management II, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pakito866Microcaps
consciousinvestor311higher debt expensive
DANGORDONBOOK VALUE GROWTH RATE
doniemaherScreen #35 - ROC>25%, Div>3%
DANGORDON1-21-19 P/E<14
efredbac10yr Low PE
mathew94Insider Buys
cspunarJuniors 21Jan19
daftheaderasian growth plus dividend
DANGORDONTECH COS RATE OF RETURN
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK